85 related articles for article (PubMed ID: 1703059)
21. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF
Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526
[TBL] [Abstract][Full Text] [Related]
22. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
[TBL] [Abstract][Full Text] [Related]
23. The absence of correlation between immunoregulatory T cells and induced lymphoproliferative response in treated B-chronic lymphocytic leukemia patients.
Milosević D; Marinković M; Colović M; Jelić S
Panminerva Med; 1999 Jun; 41(2):93-7. PubMed ID: 10479904
[TBL] [Abstract][Full Text] [Related]
24. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic heterogeneity of B cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kampalath B; Barcos MP; Stewart C
Am J Clin Pathol; 2003 Jun; 119(6):824-32. PubMed ID: 12817430
[TBL] [Abstract][Full Text] [Related]
26. Changes of T-lymphocyte-subsets and their consequences in B-CLL.
Burger T; Molnár L; Schmelczer M; Tóvári E; Szabó A; Paál M; Királyfalvi L
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):115-25. PubMed ID: 1695165
[TBL] [Abstract][Full Text] [Related]
27. CD4+/CD45RA+ 'naive' T cells and immunological response to influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients.
Marotta G; Bucalossi A; Galieni P; Bigazzi C; Nuti S; Valenzin PE; Bocchia M; Lauria F
Acta Haematol; 1998; 99(1):18-21. PubMed ID: 9490560
[TBL] [Abstract][Full Text] [Related]
28. Aberrant expression of the CD8 antigen in B cell chronic lymphocytic leukaemia.
Espinosa A; Bjørk P; Magnussen K; Moen T; Sørum Y
Leuk Lymphoma; 2003 Jan; 44(1):193-6. PubMed ID: 12691163
[TBL] [Abstract][Full Text] [Related]
29. The analysis of the variation of the surface proteins of leukemic lymphocytes of B-chronic lymphocytic leukemia patients by high performance liquid chromatography.
Wu ZW; Mackie MJ; Maddy AH
Leukemia; 1990 Dec; 4(12):851-5. PubMed ID: 2147048
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of immune function parameters in patients with chronic lymphocytic leukaemia.
Apostolopoulos A; Symeonidis A; Zoumbos N
Eur J Haematol; 1990 Jan; 44(1):39-44. PubMed ID: 2137786
[TBL] [Abstract][Full Text] [Related]
31. Functional differences of T cells in B-chronic lymphocytic leukemia.
Antica M; Kusić B; Spaventi R; Jaksić B; Vitale B
Leuk Lymphoma; 1993 Jan; 9(1-2):133-40. PubMed ID: 8477193
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in the treatment of chronic lymphocytic leukemia: defining the role of intravenous immunoglobulin.
Besa EC
Semin Hematol; 1992 Jul; 29(3 Suppl 2):14-23. PubMed ID: 1380736
[No Abstract] [Full Text] [Related]
33. Phenotypic heterogeneity of B- and T-cell differentiation antigens in B-CLL.
Merle-Beral H; Blanc C; Chastang C; Debre P
Eur J Haematol; 1988 Sep; 41(3):197-203. PubMed ID: 3263283
[TBL] [Abstract][Full Text] [Related]
34. Expression of CD45 isoforms in chronic B-cell leukaemias.
Zola H; Siderius N; Flego L; Sparrow R; van der Weyden MB; Nimmo J; Hart DN; Houghton S; Boyd AW
Leuk Res; 1993 Mar; 17(3):209-16. PubMed ID: 7680734
[TBL] [Abstract][Full Text] [Related]
35. Expression of the CDw75 (beta-galactoside alpha 2,6-sialyltransferase) antigen on normal blood cells and in B-cell chronic lymphocytic leukaemia.
Guy K; Andrew JM
Immunology; 1991 Oct; 74(2):206-14. PubMed ID: 1721040
[TBL] [Abstract][Full Text] [Related]
36. Discrete subpopulations, defined by CD45 isoforms, coexist within the leukaemic cells of B-chronic lymphocytic leukaemia patients.
Maddy A; Lyons AB; Wu ZW; Taylor H; Sanderson A; Mackie M
Leuk Res; 1991; 15(9):791-9. PubMed ID: 1833598
[TBL] [Abstract][Full Text] [Related]
37. [The use of biochips for immunomorphological diagnosis of chronic lymphocytic leukemia].
Shishkin AV; Ovchinina NG; Bessmel'tsev SS; Kozlov AV
Vopr Onkol; 2013; 59(6):761-5. PubMed ID: 24624788
[TBL] [Abstract][Full Text] [Related]
38. Differentiation and activation antigens on blood mononuclear cells in lymphocytic leukemia before and during IFN-alpha 2B therapy.
Demeter J; Paloczi K; Bibok G; Lehoczky D
Leukemia; 1992; 6 Suppl 3():41S-45S. PubMed ID: 1602826
[TBL] [Abstract][Full Text] [Related]
39. [A flow cytometric study of the effect of chemotherapy on the lymphocyte population composition in chronic lympholeukemia].
Dudko ET; Tishchenko LM; Krivozubov VB
Lik Sprava; 1992; (11-12):44-7. PubMed ID: 1292219
[TBL] [Abstract][Full Text] [Related]
40. Decreased CD45RA T cells in B-cell chronic lymphatic leukemia patients: correlation with disease stage.
Peller S; Kaufman S
Blood; 1991 Sep; 78(6):1569-73. PubMed ID: 1679357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
